The image shows the word “Human” written multiple times in different sizes and orientations on a white background.

Human First: The Future of Patient Advocacy in the Age of AI

Patients Are Asking AI First. Advocacy Groups Can Help Shape the Answers.

Download your copy of Human First: The Future of Patient Advocacy in the Age of AI today:

AI has reshaped the pathways through which patients discover and engage with health information. Our new report examines what that means for pharma, patient advocacy groups and healthcare communicators — and why human connection has never mattered more.

OpenAI recently reported that more than 300 million people ask health-related questions through ChatGPT every week. As patients increasingly turn to conversational AI to understand symptoms, treatments and diagnoses, healthcare organizations face a new challenge: ensuring that trusted information remains visible, accessible and relevant.

Human First: The Future of Patient Advocacy in the Age of AI draws on insights from VML Health's second Patient Advocacy Summit, which brought together leaders from Lung Cancer Europe, Global Health Literacy Academy, Know Your Lemons Foundation and VML Health in Madrid. It examines the ways AI has transformed the patient information journey — and assesses the implications for pharma brand teams, patient advocacy groups and healthcare communicators.

The Patient Journey Has Changed. Trust Hasn't.

Even when trusted sources inform AI's answers, patients may never see them. The question is no longer simply whether patients can access health information — it is whether they can interpret, validate and act on it.

That is where patient advocacy organizations become essential. Human connection, lived experience and empathy remain critical differentiators in an AI-enabled healthcare ecosystem. The organizations best positioned to build trust will be the ones that combine technological innovation with the insight and empathy that patients value most.

Patients don't experience healthcare through websites or search rankings. They experience it one question at a time. As AI becomes increasingly involved in answering those questions, patient advocacy organizations have an opportunity to evolve beyond providing information and towards helping people interpret, validate and act on it. We shouldn't just be optimizing patient advocacy for AI; we have to help optimize AI for patients.

Nichole Davies Global Chief Strategy Officer, VML Health

What Pharma Needs to Do Now

The report advises pharma marketing and commercial teams to rethink how they approach patient information in an AI-first world:

Assume patients ask AI first The patient information journey now begins with a conversation, not a search. Pharma teams need to plan accordingly.

Make sure AI draws on accurate, trusted content If trusted sources are not visible and accessible to AI, they risk being absent from the patient journey entirely.

Partner with patient advocacy groups Patients turn to advocacy organizations when deciding what to trust. These partnerships are no longer optional — they are strategic.

Build messages around patient needs, not brand goals Messages built around patients' real questions and concerns — and tested with real patients — will be the ones that earn trust and drive meaningful engagement.

Greater access to information only matters if patients can understand it, trust it and act on it. As AI becomes part of the patient journey, patient advocacy organizations bring something technology cannot: credibility, empathy and lived experience. Their voices must help shape the next generation of healthcare experiences if we want innovation to deliver meaningful value for patients.

Claire Gillis CEO, VML Health

The Future of Patient Advocacy

Human First concludes that the role of patient advocacy is likely to grow in the years ahead. As AI becomes more deeply integrated into healthcare communications and patient engagement, the report highlights the growing importance of transparency, governance and human oversight.

Greater collaboration between industry and patient advocacy organizations will be essential to ensure that AI-enabled experiences genuinely reflect patient needs. The summit conversations that shaped this report make clear that the opportunity — and the responsibility — to get this right sits with all of us.

Read the full report to explore the findings from VML Health's 2026 Patient Advocacy Summit and what they mean for the future of pharma, patient advocacy and healthcare communications.

Four smiling women at the Patient Advocacy Summit posing together in front of a blue Human First presentation screen.
L-R: Kristine Sørensen, Global Health Literacy Academy; Corrine Ellsworth-Beaumont, Know Your Lemons Foundation; Debra Montague, Lung Cancer Europe; Nichole Davies, VML Health

Keep reading